08:55 AM EST, 11/05/2024 (MT Newswires) -- Health care stocks were lower to flat pre-bell Tuesday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was down 0.2% recently.

Hims & Hers Health ( HIMS ) shares rose past 8% after the company reported that it swung to Q3 earnings as revenue increased during the period. The company also raised its full-year 2024 revenue guidance. In addition, Hims & Hers Health ( HIMS ) said it plans to launch a generic version of diabetes drug liraglutide on its platform in 2025.